Stock comparison

LLYvsZTS

Eli Lilly and CovsZoetis Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

LLY

Eli Lilly and Co

$917.65

-12.96%

Pharmaceuticals$884.0BNYSE

ZTS

Zoetis Inc

$116.06

-2.19%

Pharmaceuticals$48.8BNYSE

60-day price, rebased to 100

LLY -11.52% · ZTS -4.81%

Round-by-round

LLY 4·ZTS 2

EdgeZTS

Valuation upside

-70.70% vs -36.20% to DCF fair value

EdgeLLY

Balance-sheet strength

Altman Z 8.14 vs 5.39

EdgeLLY

Fundamental quality

Piotroski 8.00 vs 6.00 (of 9)

EdgeLLY

Growth + margins

Rule-of-40 53.90 vs 26.40

EdgeZTS

60-day momentum

-11.52% vs -4.81% price return

EdgeLLY

Market-cap liquidity

$884.0B vs $48.8B

Verdict

Across6categories,LLYtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onLLYorZTS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.